PERS Genetic Model Assistant Decision-making System of Neoadjuvant Chemotherapy for Breast Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
This study aims to explore new PERS prediction model can improve the pathological complete response rate of neoadjuvant chemotherapy of breast cancer and disease-free survival.
Epistemonikos ID: 6d737f455ab9b2f071faf795502b2775565e3ac4
First added on: May 20, 2024